Violence against women and resulting traumatic brain injuries increased during the COVID-19 pandemic.
Jessica Wolfe, PhD, MPH
Advertisement
Dr Wolfe is a Senior Clinical Advisor for Cohen Veterans Bioscience’s Trauma Research Programs. She serves as Strategic Advisor co-leading CVB’s Suicide Strategy Initiative.
Articles by Jessica Wolfe, PhD, MPH
In honor of the International Day for the Elimination of Violence against Women on November 25, 2021, let’s consider the impact of IPV on the neuropsychiatric health of women.
Avoiding a Brain Health Innovation Market Failure: Lessons from the Hype Cycle
ByHenry Asher,Erin Smith,Mark Heinemeyer,Michael Berk, MD, PhD,Agustin Ibañez, PhD,Shuo Chen, JD,Ernestine Fu, PhD,Jessica Wolfe, PhD, MPH,Ryan Abbott, MD, JD, PhD,Francois Véron,William Ellsworth,Marion Leboyer, MD, PhD,Geoffrey S.F. Ling, MD, PhD,Igor Linkov, PhD, MSc,Magali Haas, MD, PhD,Harris A. Eyre, MD, PhD
New approaches to ensure that the brain health technology sector continues to flourish for decades.
Information asymmetry occurs when one party has more or better information than the other party. Asymmetry and fraud will sour investor interest in the field.
The world is facing a cognition crisis. Here’s how to face it with measurement-based cognitive care.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Novel PDA10A Inhibitor for Schizophrenia in Development, Discussion With Maciej Wieczorek, MD
2
Whatever Happened to Psychopathology?
3
Positive Phase 3 Results: CTx-1301 for the Treatment of Pediatric ADHD
4
How Can Chatbots Be Made Safe for Psychiatric Patients
5
